Expertise in
5
conditions

Amit C. Nathwani

98 Chenies Mews, WC1E 6HX, 
London, ENG, GB 
Expertise in
5
conditions
98 Chenies Mews, WC1E 6HX, 
London, ENG, GB 

Overview

Amit Nathwani practices practicing medicine in London, United Kingdom.

Mr. Nathwani is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia B, Blood Clots, Hemophilia A, and Chronic Lymphocytic Leukemia (CLL).

He is actively involved in clinical research, co-authoring 81 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

98 Chenies Mews, WC1E 6HX, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open Label Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector (scAAV 2/8-LP1-hFIXco) For Gene Transfer in Hemophilia B
An Open Label Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector (scAAV 2/8-LP1-hFIXco) For Gene Transfer in Hemophilia B
Enrollment Status: Completed
Publish Date: April 02, 2026
Intervention Type: Genetic, Drug
Study Drug: scAAV2/8-LP1-hFIXco
Study Phase: Phase 1
GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3
GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2025
Intervention Type: Biological
Study Drug: AAV2/8-HLP-FVIII-V3
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

81 Total Publications

AAV Gene Therapy in Severe Hemophilia B. Reply.
AAV Gene Therapy in Severe Hemophilia B. Reply.
Journal: The New England journal of medicine
Published: August 20, 2025

Frequently Asked Questions about Amit C. Nathwani

Is Amit C. Nathwani a top-rated expert for Hemophilia B?

MediFind is an objective health platform that identifies experts based on real-world data. Amit C. Nathwani is classified as an Elite expert for Hemophilia B, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Amit C. Nathwani participate in research or clinical trials?

Yes. Amit C. Nathwani has published 81 articles and abstracts on conditions like Hemophilia B. You can view a list of Amit C. Nathwani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nathwani's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile